Product Description
| Brand |
Medtronic |
| Stent Diameter (mm) |
2.25 |
| Stent Length (mm) |
08, 12, 14, 18 & 26 |
| CAT No |
RSINT22508X, RSINT22512, RSINT22514X, RSINT22518X & RSINT22526X |
| Catheter Length |
300 cm |
Resolute Integritya is a drug-eluting stent (DES) and balloon catheter that offers excellent deliverability and flexibility for percutaneous coronary interventions.
Advanced Drug-Eluting TechnologyThe Resolute Integrity DES utilizes Zotarolimus, delivered through a biocompatible polymer coating, offering controlled and sustained drug release directly at the lesion site. This helps to minimize tissue regrowth and reduce the risk of restenosis, ensuring long-term vessel patency following implantation.
Superior Deliverability and PrecisionFeaturing a low crossing profile and continuous sinusoidal design, this stent offers exceptional flexibility and tracking. The rapid exchange (monorail) delivery system allows for simple, efficient placement through 0.014-inch guidewires, ensuring high precision and conformity within various coronary anatomies.
Safe, Reliable, and User-FriendlyPackaged sterile for single use, the Resolute Integrity DES is manufactured with robust cobalt chromium alloy, providing consistent performance and high radial strength. Its MR conditional rating allows for MRI procedures post-implantation, if necessary, with specific precautions.
FAQ's of Medtronic Resolute Integrity DES Drug-eluting Stent (SD 2.25):
Q: How does the Resolute Integrity DES (Drug-eluting Stent) SD 2.25 prevent restenosis?
A: The stent releases Zotarolimus, an anti-proliferative drug, from its biocompatible polymer coating. This controlled drug release inhibits tissue regrowth within the artery, effectively reducing the likelihood of restenosis following stent placement.
Q: What is the recommended usage process for the Resolute Integrity DES SD 2.25?
A: The stent should be deployed manually via catheter using a rapid exchange (monorail) delivery system. It is compatible with 0.014-inch guidewires and can be post-dilated up to 2.5 mm in diameter, offering flexibility for diverse vessel anatomies.
Q: When should the Resolute Integrity DES SD 2.25 be used in clinical practice?
A: This stent is indicated for the treatment of de novo coronary artery lesions in patients with coronary artery disease, particularly when a drug-eluting stent is required to minimize restenosis risk.
Q: Where can the Resolute Integrity DES SD 2.25 be utilized?
A: It is intended for use in catheterization laboratories and interventional cardiology clinics by trained medical professionals managing coronary artery disease.
Q: What are the benefits of the high radial strength and low crossing profile of this stent?
A: High radial strength helps maintain open vessel patency, resisting vessel collapse, while the low crossing profile enhances deliverability, allowing for easier navigation through narrow or complex vessel anatomies.
Q: Is the Resolute Integrity DES SD 2.25 compatible with MRI procedures?
A: Yes, this stent is MR conditional, meaning patients can undergo MRI scans under certain conditions outlined by the manufacturer. Always follow safety guidelines to ensure patient safety.
Q: What storage instructions are recommended for maintaining the Resolute Integrity DES SD 2.25's integrity?
A: Store the stent below 25C and protect it from direct sunlight. Ensure that the packaging remains sealed and sterile until use, and do not use the device after its two-year shelf life expires.